{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:22:50Z","timestamp":1746346970405},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,12,28]],"date-time":"2014-12-28T00:00:00Z","timestamp":1419724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s13277-014-2936-3","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T23:18:49Z","timestamp":1419635929000},"page":"3017-3023","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cun-bao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-hong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,28]]},"reference":[{"key":"2936_CR1","unstructured":"Stomach Cancer. Estimated incidence, mortality and prevalence worldwide in 2012. http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx , 2014."},{"key":"2936_CR2","first-page":"1","volume-title":"IARC working group on the evaluation of carcinogenic risks to humans, schistosomes, liver flukes, Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans","author":"International Agency for Research on Cancer","year":"1994","unstructured":"International Agency for Research on Cancer. IARC working group on the evaluation of carcinogenic risks to humans, schistosomes, liver flukes, Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 61. Lyon: International Agency for Research on Cancer; 1994. p. 1\u2013241."},{"issue":"Suppl 1","key":"2936_CR3","first-page":"S4","volume":"54","author":"JS Macdonald","year":"2004","unstructured":"Macdonald JS. Clinical overview: adjuvant therapy of gastrointestinal cancer. Cancer Chemother Pharmacol. 2004;54 Suppl 1:S4\u201311.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1 Suppl 3","key":"2936_CR4","first-page":"11","volume":"18","author":"DS Alberts","year":"1991","unstructured":"Alberts DS, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix: an update. Semin Oncol. 1991;18(1 Suppl 3):11\u201324.","journal-title":"Semin Oncol"},{"key":"2936_CR5","first-page":"w13275","volume":"141","author":"F Zhou","year":"2011","unstructured":"Zhou F, Yu Z, Jiang T, Lv H, Yao R, Liang J. Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients. Swiss Med Wkly. 2011;141:w13275.","journal-title":"Swiss Med Wkly"},{"issue":"4","key":"2936_CR6","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.4238\/2014.October.27.13","volume":"13","author":"L Liu","year":"2014","unstructured":"Liu L, Li CH, Jin TF, Xu DY. Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer. Genet Mol Res. 2014;13(4):8722\u20138.","journal-title":"Genet Mol Res"},{"issue":"20","key":"2936_CR7","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.3760\/cma.j.issn.0366-6999.20140081","volume":"127","author":"X Zhang","year":"2014","unstructured":"Zhang X, Bai Z, Chen B, Feng J, Yan F, Jiang Z, et al. Polymorphism of methylenetetrahydrofolate reductase gene is associated with response to fluorouracil-based chemotherapy in Chinese patients with gastric cancer. Chin Med J (Engl). 2014;127(20):3562\u20137.","journal-title":"Chin Med J (Engl)"},{"key":"2936_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2407-13-43","volume":"13","author":"SY Oh","year":"2013","unstructured":"Oh SY, Kwon HC, Kim SH, Lee S, Lee JH, Hwang JA, et al. The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer. BMC Cancer. 2013;13:43.","journal-title":"BMC Cancer"},{"issue":"1","key":"2936_CR9","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4238\/2014.March.6.2","volume":"13","author":"J Xu","year":"2014","unstructured":"Xu J, Ma J, Zong HT, Wang SY, Zhou JW. Pharmacogenetic role of XRCC1 polymorphisms on the clinical outcome of gastric cancer patients with platinum-based chemotherapy: a systematic review and meta-analysis. Genet Mol Res. 2014;13(1):1438\u201346.","journal-title":"Genet Mol Res"},{"issue":"4","key":"2936_CR10","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s13277-013-1378-7","volume":"35","author":"ZM Lu","year":"2014","unstructured":"Lu ZM, Luo TH, Nie MM, Fang GE, Ma LY, Xue XC, et al. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy. Tumour Biol. 2014;35(4):2941\u20138.","journal-title":"Tumour Biol"},{"key":"2936_CR11","doi-asserted-by":"crossref","unstructured":"Marsh S, McLeod H, Dolan E, Shukla SJ, Rabik CA, Gong L, et al. Platinum pathway. Pharmacogenet Genomics. 2009 Jul;19(7):563\u20134.","DOI":"10.1097\/FPC.0b013e32832e0ed7"},{"issue":"18","key":"2936_CR12","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1093\/nar\/gks670","volume":"40","author":"M Enoiu","year":"2012","unstructured":"Enoiu M, Jiricny J, Scharer OD. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis. Nucleic Acids Res. 2012;40(18):8953\u201364.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2936_CR13","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/carcin\/bgt214","volume":"34","author":"B Altan","year":"2013","unstructured":"Altan B, Yokobori T, Mochiki E, Ohno T, Ogata K, Ogawa A, et al. Nuclear karyopherin-\u03b12 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis. 2013;34(10):2314\u201321.","journal-title":"Carcinogenesis"},{"issue":"7","key":"2936_CR14","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI33816","volume":"119","author":"WM Abuzeid","year":"2009","unstructured":"Abuzeid WM, Jiang X, Shi G, Wang H, Paulson D, Araki K, et al. Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy. J Clin Invest. 2009;119(7):1974\u201385.","journal-title":"J Clin Invest"},{"issue":"1","key":"2936_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207\u201314.","journal-title":"Cancer"},{"issue":"4","key":"2936_CR16","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.4238\/2014.October.27.13","volume":"13","author":"L Liu","year":"2014","unstructured":"Liu L, Li CH, Jin TF, Xu DY. Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer. Genet Mol Res. 2014;13(4):8722\u20138.","journal-title":"Genet Mol Res"},{"issue":"3","key":"2936_CR17","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.4238\/2014.September.12.15","volume":"13","author":"ZH Chen","year":"2014","unstructured":"Chen ZH, Wang L, Luo LP. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer. Genet Mol Res. 2014;13(3):7484\u201391.","journal-title":"Genet Mol Res"},{"issue":"8","key":"2936_CR18","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1007\/s13277-014-1959-0","volume":"35","author":"J Li","year":"2014","unstructured":"Li J, Zuo X, Lv X, Kong F, Xu W, Yang S. Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population. Tumour Biol. 2014;35(8):7569\u201374.","journal-title":"Tumour Biol"},{"issue":"4","key":"2936_CR19","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s13277-013-1378-7","volume":"35","author":"ZM Lu","year":"2014","unstructured":"Lu ZM, Luo TH, Nie MM, Fang GE, Ma LY, Xue XC, et al. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy. Tumour Biol. 2014;35(4):2941\u20138.","journal-title":"Tumour Biol"},{"issue":"4","key":"2936_CR20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/mutage\/get023","volume":"28","author":"H Chu","year":"2013","unstructured":"Chu H, Gu D, Xu M, Xu Z, Gong Y, Gong W, et al. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 2013;28(4):441\u20136.","journal-title":"Mutagenesis"},{"issue":"9","key":"2936_CR21","doi-asserted-by":"crossref","first-page":"e71994","DOI":"10.1371\/journal.pone.0071994","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, Liu Z, Liu H, Wang LE, Tan D, Ajani JA, et al. ERCC1 and ERCC2 variants predict survival in gastric cancer patients. PLoS One. 2013;8(9):e71994.","journal-title":"PLoS One"},{"issue":"4","key":"2936_CR22","first-page":"1354","volume":"61","author":"MR Spitz","year":"2001","unstructured":"Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001;61(4):1354\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"2936_CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2478\/v10019-012-0001-7","volume":"46","author":"K Goricar","year":"2012","unstructured":"Goricar K, Erculj N, Zadel M, Dolzan V. Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage. Radiol Oncol. 2012;46(1):46\u201353.","journal-title":"Radiol Oncol"},{"issue":"10","key":"2936_CR24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/FPC.0000000000000083","volume":"24","author":"K Gori\u010dar","year":"2014","unstructured":"Gori\u010dar K, Kova\u010d V, Jazbec J, Zakotnik B, Lamovec J, Dol\u017ean V. Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma. Pharmacogenet Genomics. 2014;24(10):514\u201321.","journal-title":"Pharmacogenet Genomics"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2936-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2936-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T04:49:42Z","timestamp":1717649382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2936-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,28]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["2936"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2936-3","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,28]]}}}